Targeted therapeutic effect of anti-ABCG2 antibody combined with nano silver and vincristine on mouse myeloma cancer stem cells

Journal of Nanoparticle Research

Volumn 15, Issue 12, 2013, Pages

  Dou, Jun ^a   He, Xiangfeng ^b   Liu, Yunjing ^a   Huang, Zhihai ^a   Yang, Cuiping ^a   Shi, Fangfang ^a   Chen, Dengyu ^a   Gu, Ning ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Anti ABCG2 monoclonal antibody; Cancer stem cells; Nanomedicine; Silver nanoparticles; SP2 0 myeloma; Vincristine

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; DISEASES; MAMMALS; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; MONOCLONAL ANTIBODIES; SILVER COMPOUNDS; SILVER NANOPARTICLES;

CANCER STEM CELLS; COLONY FORMATION; MULTIPLE MYELOMA; SILVER NANOPARTICLES (AGNPS); SP2/0 MYELOMA; THERAPEUTIC EFFECTS; THERAPEUTIC METHOD; VINCRISTINE;

STEM CELLS;

ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; BREAST CANCER RESISTANCE PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CARCINOGENICITY; CD44+CD24-CELL; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL SELECTION; CELL TYPE; COLONY FORMATION; CONTROLLED STUDY; MOLECULARLY TARGETED THERAPY; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; UPREGULATION;

EID: 84887972270     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2127-y     Document Type: Article

References (33)

1. Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J, Marx AH, Uhlig R, Zustin J, Bokemeyer C, Kröger N (2012) Role of interleukin 16 in multiple myeloma. J Natl Cancer Inst 104:1005-1020
2. Carsten MT, Ralf M, Katrin K (2001) Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 61:647-653
3. + ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. BMC Cell Biol 14:7
4. Cirstea D, Hideshima T, Rodig S (2010) Dual inhibition of Akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma. Mol Cancer Ther 9:963
5. Deweerdt S (2011) Animal models: towards a myeloma mouse. Nature 480:S38-S39
6. Dou J, Gu N (2010) Emerging strategies for the identification and targeting of cancer stem cells. Tumor Biol 31:243-253
7. Dou J, Li Y, Zhao F, Hu W, Wen P, Tang Q, Jiang C, Gu N (2009) Identification of tumor stem-like cells in a mouse myeloma cell line. Cell Mol Biol (Noisy-le-grand) 55:OL1151-OL1160
8. Dou J, Jiang C, Wang J, Zhang X, Zhao F, Hu W, He X, Li X, Zou D, Gu N (2011) Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biol Int 35:227-234
9. Drain S, Flannely L, Drake MB (2011) Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. Leuk Res 35:1457-1463
10. Himes RH, Kersey RN, Heller-Bettinger I, Samson FE (1976) Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res 36:3798-3802
11. Holt RU, Fagerli UM, Baykov V, Rø TB, Hov H, Waage A, Sundan A, Børset M (2008) Hepatocyte growth factor promotes migration of human myeloma cells. Haematologica 93:619-622
12. Jakubikova J, Adamia S, Kost-Alimova M, Klippel S, Cervi D, Daley JF, Cholujova D, Kong SY, Leiba M, Blotta S, Mitsiades CS (2011) Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood 117:4409-4419
13. Jun D, Meng P, Ping W (2007) Isolation and identification of cancer stem like cells from murine melanoma cell lines. Cell Mol Immunol 4:467-472
14. Kang SJ, Ryoo IG, Lee YJ, Kwak MK (2012) Role of the Nrf2-heme oxygenase-1 pathway in silver nanoparticle-mediated cytotoxicity. Toxicol Appl Pharmacol 258:89-98
15. Khan TM, Benaich N, Malone CF, Bernardos RL, Russell AR, Hutson LD (2012) Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish. J Peripher Nerv Syst 17:76-89
16. Kim M, Turnquist H, Jackson J (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8:22-28
17. Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860-1873
18. Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, Huang Y (2012) TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials 33:6155-6161
19. - cancer cells are similarly tumorigenic. Cancer Res 65:6207-6219
20. Maranon C, Planelles L, Alonso C (2000) HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int Immunol 12:1685-1693
21. Matsui W (2011) Perspective: a model disease. Nature 480:S58
22. Matsui W, Huff CA, Wang Q (2004) Characterization of clonogenic multiple myeloma cells. Blood 103:2332-2336
23. Michael D, Tito F, Susan B (2005) Tumor stem cells and drug resistance. Nat Rev 5:275-284
24. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK (2010) MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29:5741-5754
25. Rapid Mosmann T (1983) Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
26. Rowan K (2009) Are cancer stem cells real? After four decades, debate still simmers. J Natl Cancer Inst 101:546-547
27. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Frank MH (2008) Identification of cells initiating human melanomas. Nature 451:345-349
28. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:730-735
29. Su HY, Lai HC, Lin YW (2010) Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 127:555-567
30. Thirukkumaran CM, Shi ZQ, Luider J, Kopciuk K, Gao H, Bahlis NJ, Morris D (2012) Reovirus as a viable therapeutic option for the treatment of multiple myeloma. Clin Cancer Res 18:4962-4972
31. Turner JG, Gump JL, Zhang C (2006) ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood 108:3881-3889
32. Wang J, Cao MG, You CZ, Wang CL, Liu SL, Cai K, Dou J (2012) A preliminary investigation of the relationship between circulation tumor cells and cancer stem cells in patients with breast cancer. Cell Mol Biol 58(supp):OL1641-OL1645
33. Yang Y, Shi J, Tolomelli G, Xu H, Xia J, Wang H, Zhou W, Zhou Y, Tricot G (2013) RARα2 expression confers myeloma stem cell features. Blood 122:1437-1447